Andrzej focuses on pharmaceutical and medical law as well as industrial property law and commercial law issues specific to the Life Sciences sector. He has been advising pharmaceutical companies and health care providers for a number of years.
He participates in the work on legislative changes in pharmaceutical and reimbursement law.
Andrzej advises clients on projects concerning marketing medicinal products, reimbursement processes, and contracts typical for the pharmaceutical market.
He provides holistic support for complex interdisciplinary projects involving regulatory, reimbursement, industrial property, and competition law. These projects include European market access strategies for new medicinal products (including orphan drugs), products’ rights acquisition transactions covering several European countries, and strategies for entering the generic drug market from day 1 after the original product IP protection expires.
He assists health care providers in their day-to-day operations.
Andrzej also develops his expertise in the field of intellectual property disputes, both patent and trademark.
He authored publications on medical and pharmaceutical law and is a valued speaker at Life Sciences events.
He is fluent in English.
Andrzej has been with DBS since 2016. He has served as a Partner since 2023.
A graduate of the Faculty of Law and Administration of the Jagiellonian University and the H. Grotius Center for Intellectual Property Rights. He completed the attorney-at-law apprenticeship at the District Chamber of Legal Advisers in Kraków. During his studies, he was active in the Medical Law Section of the Student Legal Counselling Office. He started his professional career in the legal department of one of the largest Polish clinical hospitals.
